Publication | Closed Access

Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged <45)

Breast OncologyOncologySalvage TreatmentMetronomic TherapyPharmacologyMetronomic Cyclophosphamide TherapyBreast CancerAdoptive Dc-cikCancer TreatmentMetronomic ChemotherapyMedicine